Open AccessEFFECT OF ZINC SULFATE ON BASIC CLINICAL AND LABORATORY MARKERS OF DIABETES
Author(s) -
Ivan Pustokhaylov,
А. А. Цибизова,
A. L. Yasenyavskaya,
Evgeniya Bakastova,
Sergey Kolosov,
Jumazia Erizhepova
Publication year - 2020
Publication title -
archiv euromedica
Language(s) - English
Resource type - Journals
eISSN - 2199-885X
pISSN - 2193-3863
DOI - 10.35630/2199-885x/2020/10/4.20
Subject(s) - glycated hemoglobin , diabetes mellitus , medicine , metformin , type 2 diabetes mellitus , carbohydrate metabolism , insulin , hemoglobin , zinc , endocrinology , type 2 diabetes , chemistry , organic chemistry
The work is devoted to evaluating the effect of zinc sulfate on the basic clinical and laboratory markers of diabetes mellitus against the background of hypoglycemic therapy with metformin hydrochloride. The study was conducted on volunteers — patients with type II diabetes mellitus. Changes in carbohydrate metabolism were studied by evaluation of blood glucose levels, C-peptide and insulin levels, glycated hemoglobin. It was found that the use of zinc drugs helps to reduce the indicators of the clinical and laboratory markers. The changes of these indicators in men were more pronounced compared to women. The supplementation of zinc sulfate into the treatment regimen of patients with type II diabetes mellitus contributes to a more effective reduction in the indicators of carbohydrate metabolism compared to the conventional therapy.